BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases

Oncogene

Volumn 21, Issue 51, 2002, Pages 7765-7775

  Greider, Courtney ^a   Chattopadhyay, Anuja ^a   Parkhurst, Christina ^a   Yang, Elizabeth ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BCL xL; BCL2; cdk; Cell cycle; Myc; p27

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; HYBRID PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN INDUCTION;

3T3 CELLS; ANIMALS; BCL-X PROTEIN; CATTLE; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; FETAL BLOOD; G1 PHASE; GENE EXPRESSION REGULATION; GENES, BCL-2; GENES, MYC; HUMANS; MICE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; S PHASE; TETRACYCLINE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0037038682     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205928     Document Type: Article

References (42)

1. Adams MR, Sears R, Nuckolls F, Leone G and Nevins JR. (2000). Mol. Cell Biol., 20, 3633-3639.
2. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J and Eilers M. (1999). EMBO J., 18, 5321-5333.
3. Brady HJ, Gil-Gomez G, Kirberg J and Berns AJ. (1996). EMBO J., 15, 6991-7001.
4. Chattopadhyay A, Chiang CW and Yang E. (2001). Oncogene, 20, 4507-4518.
5. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM and Sherr CJ. (1999). EMBO J., 18, 1571-1583.
6. Cory S, Vaux DL, Strasser A, Harris AW and Adams JM. (1999). Cancer Res., 59, 1685s-1692s.
7. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L and Coffer PJ. (2000). Mol. Cell Biol., 20, 9138-9148.
8. Eilers M, Schirm S and Bishop JM. (1991). EMBO J., 10, 133-141.
9. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP and Cleveland JL. (2001a). Oncogene, 20, 6983-6993.
10. Eischen CM, Woo D, Roussel MF and Cleveland JL. (2001b). Mol. Cell Biol., 21, 5063-5070.
11. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
12. Fanidi A, Harrington EA and Evan GI. (1992). Nature, 359, 554-556.
13. Hengstschlager M, Holzl G and Hengstschlager-Ottnad E. (1999). Oncogene, 18, 843-848.
14. Huang DC, O'Reilly LA, Strasser A and Cory S. (1997). EMBO J., 16, 4628-4638.
15. Hueber AO and Evan GI. (1998). Trends Genet., 14, 364-367.
16. Johnson DG, Schwarz JK, Cress WD and Nevins JR. (1993). Nature, 365, 349-352.
17. Kaczmarek L, Hyland JK, Watt R, Rosenberg M and Baserga R. (1985). Science, 228, 1313-1315.
18. Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, Smith C and Nevins JR. (2001). Mol. Cell, 8, 105-113.
19. Lind EF, Wayne J, Wang QZ, Staeva T, Stolzer A and Petrie HT. (1999). J. Immunol., 162, 5374-5379.
20. Linette GP, Li Y, Roth K and Korsmeyer SJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 9545-9552.
21. Marin MC, Hsu B, Stephens LC, Brisbay S and McDonnell TJ. (1995). Exp. Cell Res., 217, 240-247.
22. Mazel S, Burtrum D and Petrie HT. (1996). J. Exp. Med., 183, 2219-2226.
23. Medema RH, Kops GJ, Bos JL and Burgering BM. (2000). Nature, 404, 782-787.
24. Meyerson M and Harlow E. (1994). Mol. Cell Biol., 14, 2077-2086.
25. O'Hagan RC, Ohh M, David G, de Alboran IM, Alt FW, Kaelin Jr WG and DePinho RA. (2000). Genes Dev., 14, 2185-2191.
26. O'Reilly LA, Huang DC and Strasser A. (1996). EMBO J., 15, 6979-6990.
27. Obaya AJ, Mateyak MK and Sedivy JM. (1999). Oncogene, 18, 2934-2941.
28. Perez-Roger I, Kim SH, Griffiths B, Sewing A and Land H. (1999). EMBO J., 18, 5310-5320.
29. Perez-Roger I, Solomon DL, Sewing A and Land H. (1997). Oncogene, 14, 2373-2381.
30. Persson H, Gray HE and Godeau F. (1985). Mol. Cell Biol., 5, 2903-2912.
31. Philipp-Staheli J, Payne SR and Kemp CJ. (2001). Exp. Cell Res., 264, 148-168.
32. Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R and Rabbitts TH. (1985). EMBO J., 4, 2009-2015.
33. Resnitzky D, Gossen M, Bujard H and Reed SI. (1994). Mol. Cell Biol., 14, 1669-1679.
34. Resnitzky D and Reed SI. (1995). Mol. Cell Biol., 15, 3463-3469.
35. Sears R, Ohtani K and Nevins JR. (1997). Mol. Cell Biol., 17, 5227-5235.
36. Shan B and Lee WH. (1994). Mol. Cell Biol., 14, 8166-8173.
37. Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N and Kato Jy J. (2001). J. Biol. Chem., 9,9.
38. Tomoda K, Kubota Y and Kato J. (1999). Nature, 398, 160-165.
39. Vairo G, Innes KM and Adams JM. (1996). Oncogene, 13, 1511-1519.
40. Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A and Adams JM. (2000). Mol. Cell Biol., 20, 4745-4753.
41. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
42. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP and Sonenshein GE. (2001). Oncogene, 20, 1688-1702.